Breaking News, Financial News

Financial Report: Kendle

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle 2Q Revenues: $81.9 million (+34%) 2Q Earnings: $4.3 million (+198%) YTD Revenues: $159.1 million (+33%) YTD Earnings: $9.2 million (+156%) Comments: Service revenues for the quarter were $62.1 million, up 24%. New business awards were $84 million and contract cancellations for the quarter were $17 million. Total business authorizations, which consist of backlog, totaled $350 million. Revenues by geographic region for the quarter were 60% in the Americas, 37% in Europe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters